J Adv Prosthodont.  2016 Jun;8(3):229-234. 10.4047/jap.2016.8.3.229.

Analysis of maxillofacial prosthetics at university dental hospitals in the capital region of Korea

• Kim JH
• Shin SY
• Paek J
• Lee JH
• Kwon HB

• KMID: 2376849
• DOI: http://doi.org/10.4047/jap.2016.8.3.229

Abstract

PURPOSE
The purpose of this study was to investigate the demographic patterns of maxillofacial prosthetic treatment to identify the characteristics and geographic distribution of patients with maxillofacial prosthetics in the capital region of Korea.
MATERIALS AND METHODS
This retrospective analytical multicenter study was performed by chart reviews. This study included patients who visited the department of prosthodontics at four university dental hospitals for maxillofacial prosthetic rehabilitation. Patients with facial and congenital defects or with insufficient medical data were excluded. The patients were classified into three categories based on the location of the defect. Patients' sex, age, and residential area were analyzed. Pearson's chi-square test with a significance level of 0.05 was used to analyze the variables.
RESULTS
Among 540 patients with maxillofacial prosthetics, there were 284 (52.59%) male patients and 256 (47.41%) female patients. The number of the patients varied greatly by hospital. Most patients were older than 70, and the most common defect was a hard palate defect. Chi-square analysis did not identify any significant differences in sex, age, and distance to hospital for any defect group (P>.05).
CONCLUSION
The results of this study indicated that there was imbalance in the distribution of patients with maxillofacial prosthetic among the hospitals in the capital region of Korea. Considerations on specialists and insurance policies for the improvement of maxillofacial prosthetics in Korea are required.

Keyword

Maxillofacial prosthesis; Head and neck neoplasms; Palatal obturators; Mandibular prosthesis; Velopharyngeal insufficiency

MeSH Terms

Congenital Abnormalities
Female
Head and Neck Neoplasms
Humans
Insurance
Korea*
Male
Mandibular Prosthesis
Maxillofacial Prosthesis
Palatal Obturators
Palate, Hard
Prosthodontics
Rehabilitation
Retrospective Studies
Specialization
Velopharyngeal Insufficiency

Figure

• 

  Fig. 1 Age distribution of patients in all four dental hospitals.

Reference

1. Folz BJ, Silver CE, Rinaldo A, Fagan JJ, Pratt LW, Weir N, Seitz D, Ferlito A. An outline of the history of head and neck oncology. Oral Oncol. 2008; 44:2–9.

2. Ackerknecht EH. Historical notes on cancer. Med Hist. 1958; 2:114–119.

3. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M. Head and Neck Cancers, Version 1. 2015. J Natl Compr Canc Netw. 2015; 13:847–855.

4. Ernani V, Saba NF. Oral Cavity Cancer: Risk Factors, Pathology, and Management. Oncology. 2015; 89:187–195.

5. The glossary of prosthodontic terms. J Prosthet Dent. 2005; 94:10–92. [No authors listed].

6. Tang RY. Role of the general dentist in maxillofacial prosthetics. J Prosthet Dent. 1976; 36:416–420.

7. Beumer J 3rd, Marunick MT, Esposito SJ. Maxillofacial rehabilitation. Prosthodontic and surgical management of cancerrelated, acquired, and congenital defects of the head and neck. 3rd ed. Chicago: Quintessence Publishing Co., Inc.;2011. p. 61–254.

8. Mantri S, Khan Z. Prosthodontic rehabilitation of acquired maxillofacial defects. In : Agulnik M, editor. Head and neck cancer. Rijeka: InTech;2012. p. 315–336.

9. Oh WS, Roumanas E, Beumer J 3rd. Maxillofacial restoration after head and neck tumor therapy. Compend Contin Educ Dent. 2007; 28:70–76.

10. Yang RT, Li Z, Li ZB. Maxillofacial injuries in infants and preschools: a 2.5-year study. J Craniofac Surg. 2014; 25:964–967.

11. Hecker DM, Wiens JP, Cowper TR, Eckert SE, Gitto CA, Jacob RF, Mahanna GK, Turner GE, Potts A, Logan H, Wiens RL. American Academy of Maxillofacial Prosthetics. Can we assess quality of life in patients with head and neck cancer? A preliminary report from the American Academy of Maxillofacial Prosthetics. J Prosthet Dent. 2002; 88:344–351.

12. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee DH, Lee KH. Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat. 2015; 47:142–148.

13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893–2917.

14. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009; 45:309–316.

15. Titcomb CP Jr. High incidence of nasopharyngeal carcinoma in Asia. J Insur Med. 2001; 33:235–238.

16. Light J. Functional assessment testing for maxillofacial prosthetics. J Prosthet Dent. 1997; 77:388–393.

17. Wondergem M, Lieben G, Bouman S, van den, Lohuis PJ. Patients' satisfaction with facial prostheses. Br J Oral Maxillofac Surg. 2016; 54:394–399.

18. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002; 52:195–215.

19. Laronde DM, Hislop TG, Elwood JM, Rosin MP. Oral cancer: just the facts. J Can Dent Assoc. 2008; 74:269–272.

20. Ettinger RL, Beck JD. Geriatric dentistry: is there such a discipline? Aust Dent J. 1984; 29:355–361.

21. Turner L. Cross-border dental care: 'dental tourism' and patient mobility. Br Dent J. 2008; 204:553–554.